Head, Binance
Search every verified Ella Zhang interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Ella Zhang, managing partner and head of YZi Labs (formerly Binance Labs), discussed the firm's rebranding and expanded focus during an August 2025 appearance on theCUBE + NYSE Wired. She stated that the organization rebranded from Binance Labs to YZi Labs to broaden its scope from Web3 to include Web3 plus AI and biotech, describing this as being "at the intersection of the explosion of AI and the combination of AI and Web3 together to advance humanity." Zhang outlined the firm's three main pillars: incubation, direct investment, and liquid strategy, noting that they provide mentorship from figures including CZ and Vitalik, initial funding, and support from early stages to IPO. Zhang also commented on stablecoin adoption, describing three phases: on-chain trading, yield distribution, and now payments and cross-border capital flows, adding that regulatory clarity in the US is driving mainstream adoption. She noted that many countries are building their own stablecoins and paying attention to frameworks like the Genius Act. Regarding YZi Labs' investment approach, Zhang said the firm does not promise token listings when incubating projects, instead encouraging founders to focus on product-market fit before launching tokens. She emphasized that the firm is "open-minded" and "love[s] really crazy ideas," backing founders regardless of what they are building.
“We rebranded from Binance Labs to Easy Labs to expand our focus from Web3 to Web3 plus AI and biotech, because we are at the intersection of the explosion of AI and the combination of AI and Web3 together to advance humanity.”
“We do three main pillars: incubation, direct investment, and liquid strategy. We bring together top founders in Web3, AI, and biotech, provide world-class mentorship including CZ and Vitalik, initial funding, and support them from early stages to IPO and beyond.”
“One of the biggest problems we see in biotech is that biomarker and biodata are siloed in hospitals, clinics, universities, and labs. We aim to leverage blockchain technology to securely aggregate this data for AI training without disclosing personal information, combining security and privacy.”
“Many countries are building their own stablecoins and paying close attention to frameworks like the Genius Act. This collaborative global community could push crypto into the mainstream.”
As part of theCUBE + NYSE Wired: Crypto TrailBlazers series, YZi Labs leaders Ella Zhang, managing partner, and Alex Odagiu, ...
Sign in to search the full transcript archive, filter by topic, and access every quote from Ella Zhang.